Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy

International Archives of Allergy and Immunology

Volumn 158, Issue 1, 2012, Pages 35-42

  Moussu, Hélène ^a   Van Overtvelt, Laurence ^a   Horiot, Stéphane ^a   Tourdot, Sophie ^a   Airouche, Sabi ^a   Zuercher, Adrian ^b   Holvoet, Sébastien ^b   Prioult, Guénolée ^b   Nutten, Sophie ^b   Mercenier, Annick ^b   Mascarell, Laurent ^a   Moingeon, Philippe ^a  

^a Stallergenes SA   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bet v 1; Probiotics; Regulatory T cells; Sublingual immunotherapy

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; NCC 251; NCC 2705; NCC 453; OVALBUMIN; PROBIOTIC AGENT; RECOMBINANT BET V 1 PROTEIN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BACTERIAL STRAIN; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIRCH; CD4+ T LYMPHOCYTE; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; POLARIZATION; POLLEN; PRIORITY JOURNAL; SENSITIZATION; SUBLINGUAL IMMUNOTHERAPY; TH2 CELL;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; ANTIGENS, PLANT; BIFIDOBACTERIUM; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; DOWN-REGULATION; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; OVALBUMIN; POLLEN; PROBIOTICS;

EID: 84455202713     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000330101     Document Type: Article

References (50)

1. Wilson DR, Torres LI, Durham SR: Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003:CD002893.
2. Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW: Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol 2004; 93: 3-12, 103.
3. Pajno GB, Peroni DG, Vita D, Pietrobelli A, Parmiani S, Boner AL: Safety of sublingual immunotherapy in children with asthma. Paediatr Drugs 2003; 5: 777-781. (Pubitemid 37452626)
4. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW: Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: A metaanalysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006; 97: 141-148. (Pubitemid 44272577)
5. Mascarell L, Van Overtvelt L, Moingeon P: Novel ways for immune intervention in immunotherapy: Mucosal allergy vaccines. Immunol Allergy Clin North Am 2006; 26: 283-306.
6. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434-440. (Pubitemid 44160721)
7. Didier A, Malling HJ, Worm M, Horak F, Jager S, Montagut A, Andre C, de Beaumont O, Melac M: Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120: 1338-1345. (Pubitemid 350225683)
8. Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, Le Gall M: Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123: 160-166.
9. Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Devillier P, Montagut A, Mélac M, Galvain S, Jean-Alphonse S, Van Overtvelt L, Moingeon P, Le Gall M: Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. J Allergy Clin Immunol 2009; 124: 471-477.
10. Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, Scadding GK, Andersen JS, Riis B, Dahl R: Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol 2010; 125: 131-138.
11. Canonica G, Bousquet J, Casale T, Lockey R, Baena-Cagnani C, Pawankar R, Potter P, Bousquet P, Cox L, Durham S, Nelson H, Passalacqua G, Ryan D, Brozek J, Compalati E, Dahl R, Delgado L, van Wijk R, Gower R, Ledford D, Filho N, Valovirta E, Yusuf O, Zuberbier T, Akhanda W, Almarales R, Ansotegui I, Bonifazi F, Ceuppens J, Chivato T, Dimova D, Dumitrascu D, Fontana L, Katelaris C, Kaulsay R, Kuna P, Larenas-Linnemann D, Manoussakis M, Nekam K, Nunes C, O'Hehir R, Olaguibel J, Onder N, Park J, Priftanji A, Puy R, Sarmiento L, Scadding G, Schmid-Grendelmeier P, Seberova E, Sepiashvili R, Solé D, Togias A, Tomino C, Toskala E, Van Beever H, Vieths S: Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64: 1-59.
12. Compalati E, Passalacqua G, Bonini M, Canonica GW: The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: Results of a GA2LEN meta-analysis. Allergy 2009; 64: 1570-1579.
13. Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C: Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific Tcell tolerance, and immune deviation. J Allergy Clin Immunol 2007; 120: 707-713. (Pubitemid 47320765)
14. Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E: Sublingual immunotherapy with Dermatophagoides monomeric allergoid downregulates allergen-specific immunoglobulin E and increases both interferon-gamma-and interleukin-10-production. Clin Exp Allergy 2006; 36: 261-272. (Pubitemid 43344707)
15. Ciprandi G, Fenoglio D, Cirillo I, Vizzaccaro A, Ferrera A, Tosca MA, Puppo F: Induction of interleukin 10 by sublingual immunotherapy for house dust mites: A preliminary report. Ann Allergy Asthma Immunol 2005; 95: 38-44. (Pubitemid 41022771)
16. Savolainen J, Jacobsen L, Valovirta E: Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006; 61: 1184-1190. (Pubitemid 44326353)
17. Scadding GW, Shamji MH, Jacobson MR, Lee DI, Wilson D, Lima MT, Pitkin L, Pilette C, Nouri-Aria K, Durham SR: Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy 2010; 40: 598-606.
18. Van Overtvelt L, Lombardi V, Razafindratsita A, Saint-Lu N, Horiot S, Moussu H, Mascarell L, Moingeon P: IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol 2008; 145: 152-162.
19. Van Overtvelt L, Moussu H, Horiot S, Samson S, Lombardi V, Mascarell L, van de Moer A, Bourdet-Sicard R, Moingeon P: Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine 2010; 28: 2986-2992.
20. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M: Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebo-controlled trial. Allergy 2005; 60: 494-500. (Pubitemid 40332976)
21. Kalliomaki M, Salminen S, Poussa T, Isolauri E: Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021. (Pubitemid 46527807)
22. Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, Oldaeus G: Probiotics in prevention of IgE-associated eczema: A double-blind randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1174-1180. (Pubitemid 46654165)
23. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J: A differential effect of 2 probiotics in the preventions of eczema and atopy: A double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122: 788-794.
24. Himly M, Nony E, Chabre H, Van Overtvelt L, Neubauer A, van Ree R, Buchheit KH, Vieths S, Moingeon P, Ferreira F: Standardization of allergen products. 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation. Allergy 2009; 64: 1038-1045.
25. Mascarell L, Van Overtvelt L, Lombardi V, Razafindratsita A, Moussu H, Horiot S, Chabre H, Limal D, Moutel S, Bauer J, Chiavaroli C, Moingeon P: A synthetic triacylated pseudo-dipeptide molecule promotes Th1/ Treg immune responses and enhances tolerance induction via the sublingual route. Vaccine 2007; 26: 108-118. (Pubitemid 350213205)
26. Lombardi V, Van Overtvelt L, Horiot S, Moussu H, Chabre H, Louise A, Balazuc AM, Mascarell L, Moingeon P: Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route. Clin Exp Allergy 2008; 38: 1819-1829.
27. Allam JP, Novak N, Fuchs C, Asen S, Berge S, Appel T, Geiger E, Kochan JP, Bieber T: Characterization of dendritic cells from human oral mucosa: A new Langerhans' cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 2003; 112: 141-148. (Pubitemid 36819819)
28. Allam JP, Peng WM, Appel T, Wenghoefer M, Niederhagen B, Bieber T, Berge S, Novak N: Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008; 121: 368-374.
29. Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, Novak N: Distribution of Langerhans cells and mast cells within the human oral mucosa: New application sites of allergens in sublingual immunotherapy? Allergy 2008; 63: 720-727. (Pubitemid 351591847)
30. Mascarell L, Lombardi V, Louise A, Saint-Lu N, Chabre H, Moussu H, Betbeder D, Balazuc AM, Van Overtvelt L, Moingeon P: Oral dendritic cells mediate antigen-specific tolerance by stimulating Th1 and regulatory CD4+ T cells. J Allergy Clin Immunol 2008; 122: 603-609.
31. Mascarell L, Lombardi V, Zimmer A, Louise A, Tourdot S, Van Overtvelt L, Moingeon P: Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells. Clin Exp Allergy 2009; 39: 1910-1919.
32. Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, Sirard J-C, Pot B, Grangette C: A key role of dendritic cells in probiotic functionality. PLoS ONE 2007; 2:e313.
33. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y: Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 2006; 117: 696-702. (Pubitemid 43340238)
34. Smits HH, Engering A, van der Kleij D, de Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probiotic bacteria induce IL-10 producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell 'specific intercellular adhesion molecule' 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115: 1260-1267. (Pubitemid 40824599)
35. Schabussova I, Wiedermann U: Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases. Curr Opin Allergy Clin Immunol 2008; 8: 557-564.
36. Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B, Pestel J, Jacquet A: Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 2009; 64: 406-414.
37. Repa A, Grangette C, Daniel C, Hochreiter R, Hoffmann-Sommergruber K, Thalhamer J, Kraft D, Breiteneder H, Mercenier A, Wiedermann U: Mucosal co-application of lactic acid bacteria and allergen induces counterregulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003; 22: 87-95. (Pubitemid 37357155)
38. Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, Saito T: Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol 2006; 145: 130-138. (Pubitemid 43893942)
39. Feleszko W, Jawaorska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, Ahrens B, Groneverg DA, Wahn U, Hamelmann E: Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007; 37: 498-505. (Pubitemid 46537735)
40. Niers LE, Hoekstra MO, Timmerman HM, van Uden NO, de Graaf PM, Smits HH, Kimpen JL, Rijkers GT: Selection of probiotic bacteria for prevention of allergic diseases: Immunomodulation of neonatal dendritic cells. Clin Exp Immunol 2007; 149: 344-352. (Pubitemid 47063056)
41. Kim JY, Choi YO, Ji GE: Effect of oral probiotics ( Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol 2008; 18: 1393-1400.
42. Xiao JZ, Kondo S, Yanagisawa N, Takahashi N, Odamaki T, Iwabuchi N, Iwatsuki K, Togashi H, Enomoto K, Enomoto T: Probiotics in the treatment of Japanese cedar pollinosis: A double-blind placebo-controlled trial. Clin Exp Allergy 2006; 36: 1425-1435. (Pubitemid 44674127)
43. Trebichavsky I, Rada V, Splichalova A, Splichal I: Cross-talk of human gut with bifidobacteria. Nutr Rev 2009; 67: 77-82.
44. Roselli M, Finamore A, Nuccitelli S, Carnevali P, Brigidi P, Vitali B, Nobili F, Rami R, Garaguso I, Mengheri E: Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 2009; 15: 1526-1536.
45. Lyons A, O'Mahony D, O'Brien F, MacSharry J, Sheil B, Ceddia M, Russell WM, Forsythe P, Bienenstock J, Kiely B, Shanahan F, O'Mahony L: Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 2010; 40: 811-819.
46. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, Hoekstra MO, de Kleer IM: Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 2010; 40: 103-110.
47. Medina M, Izquierdo E, Ennahar S, Sanz Y: Differential immunomodulatory properties of Bifidobacterium longum strains: Relevance to probiotic selection and clinical applications. Clin Exp Immunol 2007; 150: 531-538. (Pubitemid 350098744)
48. Wang Z, Hong J, Sun W, Xu G, Li N, Chen X, Liu A, Xu L, Sun B, Zhang JZ: Role of IFNgamma in induction of Foxp 3 and conversion of CD4+ CD25-T cells to CD4+ Tregs. J Clin Invest 2006; 116: 2434-2441. (Pubitemid 44330142)
49. Saraiva M, O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10: 170-181.
50. Weidenmaier C, Peschel A: Teichoic acids and related cell-wall glycomers in Grampositive physiology and host interactions. Nat Rev Microbiol 2008; 6: 276-287. (Pubitemid 351404772)